1,915 reports of this reaction
3.5% of all IXAZOMIB reports
#6 most reported adverse reaction
FATIGUE is the #6 most commonly reported adverse reaction for IXAZOMIB, manufactured by Takeda Pharmaceuticals America, Inc.. There are 1,915 FDA adverse event reports linking IXAZOMIB to FATIGUE. This represents approximately 3.5% of all 55,273 adverse event reports for this drug.
Patients taking IXAZOMIB who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among IXAZOMIB users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for IXAZOMIB:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 1,915 FDA reports for IXAZOMIB. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 3.5% of all adverse event reports for IXAZOMIB, making it a notable side effect.
If you experience fatigue while taking IXAZOMIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.